MetaCap

Cytokinetics Insider Trades

NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

62.91+0.90 (+1.45%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
31 · $22.85M
Shares bought / sold
0 / 305.33K
Net activity
Net selling $22.9 million

Cytokinetics insider activity

Over the last 12 months, Cytokinetics insiders reported 76 transactions on SEC Form 4: 0 open-market purchases and 31 sales. Insiders bought $0 and sold $22.9 million worth of stock, for net insider selling of $22.9 million. The largest seller was Blum Robert I, with $11.9 million in reported sales.

The most recent filing shows Malik Fady Ibraham (EVP Research & Development) reporting a transaction in 3,500 shares at $7.80 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CYTK's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CYTK insider transactions

Cytokinetics insider transactions
DateInsiderTypeSharesValueFiling
Oct 6, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$214.83KForm 4
Oct 6, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Sep 28, 2026Blum Robert IPresident & CEOSale7,500$490.95KForm 4
Sep 28, 2026Blum Robert IPresident & CEOOption exercise7,500$79.50KForm 4
Sep 22, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$239.01KForm 4
Sep 22, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Sep 15, 2026Blum Robert IPresident & CEOSale97,926$6.79MForm 4
Sep 15, 2026Landry Robert EDirectorSale1,000$72.13KForm 4
Sep 14, 2026Blum Robert IPresident & CEOGift97,926—Form 4
Sep 14, 2026Blum Robert IPresident & CEOGift97,926—Form 4
Sep 14, 2026Blum Robert IPresident & CEOGift1,350—Form 4
Sep 14, 2026Blum Robert IPresident & CEOSale7,500$550.80KForm 4
Sep 14, 2026Blum Robert IPresident & CEOOption exercise7,500$79.50KForm 4
Sep 11, 2026Landry Robert EDirectorSale1,000$74.66KForm 4
Sep 8, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$264.11KForm 4
Sep 8, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Sep 1, 2026PARSHALL B LYNNEDirectorSale5,000$357.40KForm 4
Aug 31, 2026Blum Robert IPresident & CEOSale7,500$526.80KForm 4
Aug 31, 2026Blum Robert IPresident & CEOOption exercise7,500$79.50KForm 4
Aug 31, 2026Callos AndrewEVP, Chief Commercial OfficerSale10,000$702.40KForm 4
Aug 31, 2026Callos AndrewEVP, Chief Commercial OfficerOption exercise10,000$232.60KForm 4
Aug 18, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$265.37KForm 4
Aug 18, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Aug 10, 2026Blum Robert IPresident & CEOSale7,500$575.70KForm 4
Aug 10, 2026Blum Robert IPresident & CEOOption exercise7,500$79.50KForm 4
Jul 30, 2026Callos AndrewEVP, Chief Commercial OfficerSale14,000$1.12MForm 4
Jul 30, 2026Callos AndrewEVP, Chief Commercial OfficerOption exercise14,000$325.64KForm 4
Jul 27, 2026Blum Robert IPresident & CEOSale7,500$606.52KForm 4
Jul 27, 2026Blum Robert IPresident & CEOOption exercise7,500$79.50KForm 4
Jul 21, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$282.06KForm 4
Jul 21, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Jul 15, 2026Harrington Robert ArthurDirectorAward151$12.48KForm 4
Jul 15, 2026WIERENGA WENDELLDirectorAward75$6.20KForm 4
Jul 15, 2026Daly James MDirectorAward151$12.48KForm 4
Jul 15, 2026HENDERSON JOHN TDirectorAward272$22.47KForm 4
Jul 15, 2026Kaye Edward M. MDDirectorAward151$12.48KForm 4
Jul 15, 2026Wysenski NancyDirectorAward75$6.20KForm 4
Jul 13, 2026Blum Robert IPresident & CEOSale7,490$614.33KForm 4
Jul 13, 2026Blum Robert IPresident & CEOOption exercise7,490$79.39KForm 4
Jul 13, 2026Blum Robert IPresident & CEOSale10$820.20Form 4
Jul 7, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$303.17KForm 4
Jul 7, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Jul 1, 2026Lee SungEVP, Chief Financial OfficerSale1,112$97.62KForm 4
Jul 1, 2026Lee SungEVP, Chief Financial OfficerOption exercise1,112$53.94KForm 4
Jul 1, 2026Blum Robert IPresident & CEOSale7,500$636.90KForm 4
Jul 1, 2026Callos AndrewEVP, Chief Commercial OfficerSale15,000$1.29MForm 4
Jul 1, 2026Callos AndrewEVP, Chief Commercial OfficerOption exercise15,000$348.90KForm 4
Jun 29, 2026Lee SungEVP, Chief Financial OfficerSale3,134$266.39KForm 4
Jun 29, 2026Lee SungEVP, Chief Financial OfficerOption exercise823$36.51KForm 4
Jun 29, 2026Lee SungEVP, Chief Financial OfficerOption exercise188$8.34KForm 4
Jun 29, 2026Lee SungEVP, Chief Financial OfficerOption exercise1,113$53.99KForm 4
Jun 29, 2026Lee SungEVP, Chief Financial OfficerOption exercise822$36.46KForm 4
Jun 29, 2026Lee SungEVP, Chief Financial OfficerOption exercise188$8.34KForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerSale38,730$3.19MForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerOption exercise1,113$53.99KForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerOption exercise822$36.46KForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerOption exercise188$8.34KForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerOption exercise1,113$53.99KForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerOption exercise2,817$124.96KForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerOption exercise9,307$412.86KForm 4
Jun 24, 2026Lee SungEVP, Chief Financial OfficerOption exercise23,370$1.13MForm 4
Jun 23, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$278.29KForm 4
Jun 23, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Jun 15, 2026Blum Robert IPresident & CEOSale7,500$528.45KForm 4
Jun 9, 2026Malik Fady IbrahamEVP Research & DevelopmentSale3,500$237.93KForm 4
Jun 9, 2026Malik Fady IbrahamEVP Research & DevelopmentOption exercise3,500$27.30KForm 4
Jun 1, 2026PARSHALL B LYNNEDirectorSale5,000$370.40KForm 4
Jun 1, 2026Kaye Edward M. MDDirectorSale2,933$223.17KForm 4
Jun 1, 2026Callos AndrewEVP, Chief Commercial OfficerSale15,000$1.11MForm 4
Jun 1, 2026Callos AndrewEVP, Chief Commercial OfficerOption exercise15,000$348.90KForm 4
May 27, 2026HENDERSON JOHN TDirectorAward2,851—Form 4
May 27, 2026Harrington Robert ArthurDirectorAward2,851—Form 4
May 27, 2026Daly James MDirectorAward2,851—Form 4
May 27, 2026Kaye Edward M. MDDirectorAward2,851—Form 4
May 27, 2026Bhanji MunaDirectorAward2,851—Form 4
May 27, 2026Blum Robert IPresident & CEOSale7,500$579.08KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related